News

Biotechnology advances the plastics industry by employing living cells and enzymes to create eco-friendly solutions and ...
Fortress Biotech, Inc.’s FBIO share price has dipped by 6.18%, which has investors questioning if this is right time to buy.
Anbio Biotechnology’s NNNN share price has surged by 5.23%, which has investors questioning if this is right time to sell.
This pharmaceutical biotechnology company announced a significant milestone in its global intellectual property strategy. The ...
Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...
Fortress Biotech, Inc. ("Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to ...
Dr Matthias Magoola, the founder and managing director of Dei Biopharma Ltd, has been awarded one of the continent’s top ...
Rigel Pharmaceuticals, Inc.'s 68% YoY revenue growth signals durable stock potential. Click for my RIGL earnings update and a ...
From connectors and containers to plasmids and platforms, companies work to get these treatments to patients faster and more ...
Takeda has shot down candidates acquired in its $525 million Maverick Therapeutics takeover, blowing a hole in its oncology R ...
Discover the Top 12 American Skincare Brands [Update 2025] dominating the beauty scene with innovative, effective products ...
The success of Cuba's health biotechnology sector Cuban-based biotechnology has already produced a wide array of products. When 32 Cuban experts interviewed for this study were asked to identify ...